Primary CNS lymphoma of T-cell origin: A descriptive analysis from the International Primary CNS Lymphoma Collaborative Group
Identifieur interne : 00A489 ( Main/Exploration ); précédent : 00A488; suivant : 00A490Primary CNS lymphoma of T-cell origin: A descriptive analysis from the International Primary CNS Lymphoma Collaborative Group
Auteurs : Tamara N. Shenkier [Canada, France, États-Unis, Pays-Bas, Allemagne, Italie, Australie] ; Jean-Yves Blay ; Brian Patrick O'Neill ; Philip Poortmans ; Eckhard Thiel ; Kristoph Jahnke ; Lauren E. Abrey ; Edward Neuwelt ; Richard Tsang ; Tracy Batchelor ; Nancy Harris ; Andrés J. M. Ferreri ; Maurilio Ponzoni ; Peter O'Brien ; James Rubenstein ; Joseph M. ConnorsSource :
- Journal of clinical oncology [ 0732-183X ] ; 2005.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Purpose To describe the demographic and tumor related characteristics and outcomes for patients with primary T-cell CNS lymphoma (TPCNSL). Patients and Methods A retrospective series of patients with TPCNSL was compiled from twelve cancer centers in seven countries. Results We identified 45 patients with a median age of 60 years (range, 3 to 84 years). Twenty (44%) had Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1. Twenty-six (58%) had involvement of a cerebral hemisphere and sixteen (36%) had lesions of deeper sites in the brain. Serum lactate dehydrogenase was elevated in 7 (32%) of 22 patients, and CSF protein was elevated in 19 of 24 patients (79%) with available data. The median disease-specific survival (DSS) was 25 months (95% Cl, 11 to 38 months). The 2- and 5-year DSS were 51% (95% Cl, 35% to 66%) and 17% (95% Cl, 6% to 34%), respectively. Univariate and multivariate analyses were conducted for age (< 60 v > 60 years), PS (0 or 1 v 2, 3, or 4), involvement of deep structures of the CNS (no v yes), and methotrexate (MTX) use in the primary treatment (yes v no). Only PS and MTX use were significantly associated with better outcome with hazard ratios of 0.2 (95% Cl, 0.1 to 0.4) and 0.4 (95% Cl, 0.2 to 0.8), respectively. Conclusion This is the largest series ever assembled of TPCNSL. The presentation and outcome appear similar to that of B cell PCNSL. PS 0 or 1 and administration of MTX are associated with better survival.
Affiliations:
- Allemagne, Australie, Canada, France, Italie, Pays-Bas, États-Unis
- Auvergne-Rhône-Alpes, Berlin, Lombardie, Rhône-Alpes
- Berlin, Lyon, Milan
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 004993
- to stream PascalFrancis, to step Curation: 001710
- to stream PascalFrancis, to step Checkpoint: 004436
- to stream Main, to step Merge: 00B086
- to stream Main, to step Curation: 00A489
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Primary CNS lymphoma of T-cell origin: A descriptive analysis from the International Primary CNS Lymphoma Collaborative Group</title>
<author><name sortKey="Shenkier, Tamara N" sort="Shenkier, Tamara N" uniqKey="Shenkier T" first="Tamara N." last="Shenkier">Tamara N. Shenkier</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Medical Oncology, British Columbia Cancer Agency</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Radiation Oncology, Princess Margaret Hospital</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Unite Cytokines et Cancers, Hôpital Edouard Herriot, Centre Leon Berard</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Neuro-Oncology Program, Mayo Clinic Cancer Center</s1>
<s2>Rochester, MN</s2>
<s3>USA</s3>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Rochester, MN</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Dr Bernard Verbeeten Instituut</s1>
<s2>Tilburg</s2>
<s3>NLD</s3>
</inist:fA14>
<country>Pays-Bas</country>
<wicri:noRegion>Dr Bernard Verbeeten Instituut</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><inist:fA14 i1="06"><s1>Charite Campus Benjamin Franklin</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Department of Neurology, Memorial Sloan-Kettering Cancer Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New York, NY</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Department of Neurology and Neurosurgery, Oregon Health & Science University</s1>
<s2>Portland, OR</s2>
<s3>USA</s3>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Portland, OR</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Department of Neurology and Pathology, Harvard Medical School</s1>
<s3>USA</s3>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Department of Neurology and Pathology, Harvard Medical School</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Massachusetts General Hospital</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Massachusetts General Hospital</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><inist:fA14 i1="11"><s1>Department of Radiochemotherapy and Pathology, San Raffaele H Scientific Institute</s1>
<s2>Milan</s2>
<s3>ITA</s3>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Department of Radiation Oncology, Newcastle Mater Hospital</s1>
<s2>Newcastle</s2>
<s3>AUS</s3>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Newcastle</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="13"><s1>University of California San Francisco</s1>
<s2>San Francisco, CA</s2>
<s3>USA</s3>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>University of California San Francisco</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Blay, Jean Yves" sort="Blay, Jean Yves" uniqKey="Blay J" first="Jean-Yves" last="Blay">Jean-Yves Blay</name>
</author>
<author><name sortKey="O Neill, Brian Patrick" sort="O Neill, Brian Patrick" uniqKey="O Neill B" first="Brian Patrick" last="O'Neill">Brian Patrick O'Neill</name>
</author>
<author><name sortKey="Poortmans, Philip" sort="Poortmans, Philip" uniqKey="Poortmans P" first="Philip" last="Poortmans">Philip Poortmans</name>
</author>
<author><name sortKey="Thiel, Eckhard" sort="Thiel, Eckhard" uniqKey="Thiel E" first="Eckhard" last="Thiel">Eckhard Thiel</name>
</author>
<author><name sortKey="Jahnke, Kristoph" sort="Jahnke, Kristoph" uniqKey="Jahnke K" first="Kristoph" last="Jahnke">Kristoph Jahnke</name>
</author>
<author><name sortKey="Abrey, Lauren E" sort="Abrey, Lauren E" uniqKey="Abrey L" first="Lauren E." last="Abrey">Lauren E. Abrey</name>
</author>
<author><name sortKey="Neuwelt, Edward" sort="Neuwelt, Edward" uniqKey="Neuwelt E" first="Edward" last="Neuwelt">Edward Neuwelt</name>
</author>
<author><name sortKey="Tsang, Richard" sort="Tsang, Richard" uniqKey="Tsang R" first="Richard" last="Tsang">Richard Tsang</name>
</author>
<author><name sortKey="Batchelor, Tracy" sort="Batchelor, Tracy" uniqKey="Batchelor T" first="Tracy" last="Batchelor">Tracy Batchelor</name>
</author>
<author><name sortKey="Harris, Nancy" sort="Harris, Nancy" uniqKey="Harris N" first="Nancy" last="Harris">Nancy Harris</name>
</author>
<author><name sortKey="Ferreri, Andres J M" sort="Ferreri, Andres J M" uniqKey="Ferreri A" first="Andrés J. M." last="Ferreri">Andrés J. M. Ferreri</name>
</author>
<author><name sortKey="Ponzoni, Maurilio" sort="Ponzoni, Maurilio" uniqKey="Ponzoni M" first="Maurilio" last="Ponzoni">Maurilio Ponzoni</name>
</author>
<author><name sortKey="O Brien, Peter" sort="O Brien, Peter" uniqKey="O Brien P" first="Peter" last="O'Brien">Peter O'Brien</name>
</author>
<author><name sortKey="Rubenstein, James" sort="Rubenstein, James" uniqKey="Rubenstein J" first="James" last="Rubenstein">James Rubenstein</name>
</author>
<author><name sortKey="Connors, Joseph M" sort="Connors, Joseph M" uniqKey="Connors J" first="Joseph M." last="Connors">Joseph M. Connors</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0201572</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0201572 INIST</idno>
<idno type="RBID">Pascal:05-0201572</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">004993</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001710</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">004436</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">004436</idno>
<idno type="wicri:doubleKey">0732-183X:2005:Shenkier T:primary:cns:lymphoma</idno>
<idno type="wicri:Area/Main/Merge">00B086</idno>
<idno type="wicri:Area/Main/Curation">00A489</idno>
<idno type="wicri:Area/Main/Exploration">00A489</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Primary CNS lymphoma of T-cell origin: A descriptive analysis from the International Primary CNS Lymphoma Collaborative Group</title>
<author><name sortKey="Shenkier, Tamara N" sort="Shenkier, Tamara N" uniqKey="Shenkier T" first="Tamara N." last="Shenkier">Tamara N. Shenkier</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Medical Oncology, British Columbia Cancer Agency</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Radiation Oncology, Princess Margaret Hospital</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Unite Cytokines et Cancers, Hôpital Edouard Herriot, Centre Leon Berard</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Neuro-Oncology Program, Mayo Clinic Cancer Center</s1>
<s2>Rochester, MN</s2>
<s3>USA</s3>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Rochester, MN</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Dr Bernard Verbeeten Instituut</s1>
<s2>Tilburg</s2>
<s3>NLD</s3>
</inist:fA14>
<country>Pays-Bas</country>
<wicri:noRegion>Dr Bernard Verbeeten Instituut</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><inist:fA14 i1="06"><s1>Charite Campus Benjamin Franklin</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Department of Neurology, Memorial Sloan-Kettering Cancer Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New York, NY</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Department of Neurology and Neurosurgery, Oregon Health & Science University</s1>
<s2>Portland, OR</s2>
<s3>USA</s3>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Portland, OR</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Department of Neurology and Pathology, Harvard Medical School</s1>
<s3>USA</s3>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Department of Neurology and Pathology, Harvard Medical School</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Massachusetts General Hospital</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Massachusetts General Hospital</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><inist:fA14 i1="11"><s1>Department of Radiochemotherapy and Pathology, San Raffaele H Scientific Institute</s1>
<s2>Milan</s2>
<s3>ITA</s3>
</inist:fA14>
<country>Italie</country>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Department of Radiation Oncology, Newcastle Mater Hospital</s1>
<s2>Newcastle</s2>
<s3>AUS</s3>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Newcastle</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="13"><s1>University of California San Francisco</s1>
<s2>San Francisco, CA</s2>
<s3>USA</s3>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>University of California San Francisco</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Blay, Jean Yves" sort="Blay, Jean Yves" uniqKey="Blay J" first="Jean-Yves" last="Blay">Jean-Yves Blay</name>
</author>
<author><name sortKey="O Neill, Brian Patrick" sort="O Neill, Brian Patrick" uniqKey="O Neill B" first="Brian Patrick" last="O'Neill">Brian Patrick O'Neill</name>
</author>
<author><name sortKey="Poortmans, Philip" sort="Poortmans, Philip" uniqKey="Poortmans P" first="Philip" last="Poortmans">Philip Poortmans</name>
</author>
<author><name sortKey="Thiel, Eckhard" sort="Thiel, Eckhard" uniqKey="Thiel E" first="Eckhard" last="Thiel">Eckhard Thiel</name>
</author>
<author><name sortKey="Jahnke, Kristoph" sort="Jahnke, Kristoph" uniqKey="Jahnke K" first="Kristoph" last="Jahnke">Kristoph Jahnke</name>
</author>
<author><name sortKey="Abrey, Lauren E" sort="Abrey, Lauren E" uniqKey="Abrey L" first="Lauren E." last="Abrey">Lauren E. Abrey</name>
</author>
<author><name sortKey="Neuwelt, Edward" sort="Neuwelt, Edward" uniqKey="Neuwelt E" first="Edward" last="Neuwelt">Edward Neuwelt</name>
</author>
<author><name sortKey="Tsang, Richard" sort="Tsang, Richard" uniqKey="Tsang R" first="Richard" last="Tsang">Richard Tsang</name>
</author>
<author><name sortKey="Batchelor, Tracy" sort="Batchelor, Tracy" uniqKey="Batchelor T" first="Tracy" last="Batchelor">Tracy Batchelor</name>
</author>
<author><name sortKey="Harris, Nancy" sort="Harris, Nancy" uniqKey="Harris N" first="Nancy" last="Harris">Nancy Harris</name>
</author>
<author><name sortKey="Ferreri, Andres J M" sort="Ferreri, Andres J M" uniqKey="Ferreri A" first="Andrés J. M." last="Ferreri">Andrés J. M. Ferreri</name>
</author>
<author><name sortKey="Ponzoni, Maurilio" sort="Ponzoni, Maurilio" uniqKey="Ponzoni M" first="Maurilio" last="Ponzoni">Maurilio Ponzoni</name>
</author>
<author><name sortKey="O Brien, Peter" sort="O Brien, Peter" uniqKey="O Brien P" first="Peter" last="O'Brien">Peter O'Brien</name>
</author>
<author><name sortKey="Rubenstein, James" sort="Rubenstein, James" uniqKey="Rubenstein J" first="James" last="Rubenstein">James Rubenstein</name>
</author>
<author><name sortKey="Connors, Joseph M" sort="Connors, Joseph M" uniqKey="Connors J" first="Joseph M." last="Connors">Joseph M. Connors</name>
</author>
</analytic>
<series><title level="j" type="main">Journal of clinical oncology</title>
<title level="j" type="abbreviated">J. clin. oncol.</title>
<idno type="ISSN">0732-183X</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of clinical oncology</title>
<title level="j" type="abbreviated">J. clin. oncol.</title>
<idno type="ISSN">0732-183X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cancerology</term>
<term>Cell origin</term>
<term>International</term>
<term>Lymphoma</term>
<term>Primary</term>
<term>T-Lymphocyte</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Lymphome</term>
<term>Primaire</term>
<term>Lymphocyte T</term>
<term>Origine cellule</term>
<term>International</term>
<term>Cancérologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Purpose To describe the demographic and tumor related characteristics and outcomes for patients with primary T-cell CNS lymphoma (TPCNSL). Patients and Methods A retrospective series of patients with TPCNSL was compiled from twelve cancer centers in seven countries. Results We identified 45 patients with a median age of 60 years (range, 3 to 84 years). Twenty (44%) had Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1. Twenty-six (58%) had involvement of a cerebral hemisphere and sixteen (36%) had lesions of deeper sites in the brain. Serum lactate dehydrogenase was elevated in 7 (32%) of 22 patients, and CSF protein was elevated in 19 of 24 patients (79%) with available data. The median disease-specific survival (DSS) was 25 months (95% Cl, 11 to 38 months). The 2- and 5-year DSS were 51% (95% Cl, 35% to 66%) and 17% (95% Cl, 6% to 34%), respectively. Univariate and multivariate analyses were conducted for age (< 60 v > 60 years), PS (0 or 1 v 2, 3, or 4), involvement of deep structures of the CNS (no v yes), and methotrexate (MTX) use in the primary treatment (yes v no). Only PS and MTX use were significantly associated with better outcome with hazard ratios of 0.2 (95% Cl, 0.1 to 0.4) and 0.4 (95% Cl, 0.2 to 0.8), respectively. Conclusion This is the largest series ever assembled of TPCNSL. The presentation and outcome appear similar to that of B cell PCNSL. PS 0 or 1 and administration of MTX are associated with better survival.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
<li>Australie</li>
<li>Canada</li>
<li>France</li>
<li>Italie</li>
<li>Pays-Bas</li>
<li>États-Unis</li>
</country>
<region><li>Auvergne-Rhône-Alpes</li>
<li>Berlin</li>
<li>Lombardie</li>
<li>Rhône-Alpes</li>
</region>
<settlement><li>Berlin</li>
<li>Lyon</li>
<li>Milan</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Abrey, Lauren E" sort="Abrey, Lauren E" uniqKey="Abrey L" first="Lauren E." last="Abrey">Lauren E. Abrey</name>
<name sortKey="Batchelor, Tracy" sort="Batchelor, Tracy" uniqKey="Batchelor T" first="Tracy" last="Batchelor">Tracy Batchelor</name>
<name sortKey="Blay, Jean Yves" sort="Blay, Jean Yves" uniqKey="Blay J" first="Jean-Yves" last="Blay">Jean-Yves Blay</name>
<name sortKey="Connors, Joseph M" sort="Connors, Joseph M" uniqKey="Connors J" first="Joseph M." last="Connors">Joseph M. Connors</name>
<name sortKey="Ferreri, Andres J M" sort="Ferreri, Andres J M" uniqKey="Ferreri A" first="Andrés J. M." last="Ferreri">Andrés J. M. Ferreri</name>
<name sortKey="Harris, Nancy" sort="Harris, Nancy" uniqKey="Harris N" first="Nancy" last="Harris">Nancy Harris</name>
<name sortKey="Jahnke, Kristoph" sort="Jahnke, Kristoph" uniqKey="Jahnke K" first="Kristoph" last="Jahnke">Kristoph Jahnke</name>
<name sortKey="Neuwelt, Edward" sort="Neuwelt, Edward" uniqKey="Neuwelt E" first="Edward" last="Neuwelt">Edward Neuwelt</name>
<name sortKey="O Brien, Peter" sort="O Brien, Peter" uniqKey="O Brien P" first="Peter" last="O'Brien">Peter O'Brien</name>
<name sortKey="O Neill, Brian Patrick" sort="O Neill, Brian Patrick" uniqKey="O Neill B" first="Brian Patrick" last="O'Neill">Brian Patrick O'Neill</name>
<name sortKey="Ponzoni, Maurilio" sort="Ponzoni, Maurilio" uniqKey="Ponzoni M" first="Maurilio" last="Ponzoni">Maurilio Ponzoni</name>
<name sortKey="Poortmans, Philip" sort="Poortmans, Philip" uniqKey="Poortmans P" first="Philip" last="Poortmans">Philip Poortmans</name>
<name sortKey="Rubenstein, James" sort="Rubenstein, James" uniqKey="Rubenstein J" first="James" last="Rubenstein">James Rubenstein</name>
<name sortKey="Thiel, Eckhard" sort="Thiel, Eckhard" uniqKey="Thiel E" first="Eckhard" last="Thiel">Eckhard Thiel</name>
<name sortKey="Tsang, Richard" sort="Tsang, Richard" uniqKey="Tsang R" first="Richard" last="Tsang">Richard Tsang</name>
</noCountry>
<country name="Canada"><noRegion><name sortKey="Shenkier, Tamara N" sort="Shenkier, Tamara N" uniqKey="Shenkier T" first="Tamara N." last="Shenkier">Tamara N. Shenkier</name>
</noRegion>
<name sortKey="Shenkier, Tamara N" sort="Shenkier, Tamara N" uniqKey="Shenkier T" first="Tamara N." last="Shenkier">Tamara N. Shenkier</name>
</country>
<country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Shenkier, Tamara N" sort="Shenkier, Tamara N" uniqKey="Shenkier T" first="Tamara N." last="Shenkier">Tamara N. Shenkier</name>
</region>
</country>
<country name="États-Unis"><noRegion><name sortKey="Shenkier, Tamara N" sort="Shenkier, Tamara N" uniqKey="Shenkier T" first="Tamara N." last="Shenkier">Tamara N. Shenkier</name>
</noRegion>
<name sortKey="Shenkier, Tamara N" sort="Shenkier, Tamara N" uniqKey="Shenkier T" first="Tamara N." last="Shenkier">Tamara N. Shenkier</name>
<name sortKey="Shenkier, Tamara N" sort="Shenkier, Tamara N" uniqKey="Shenkier T" first="Tamara N." last="Shenkier">Tamara N. Shenkier</name>
<name sortKey="Shenkier, Tamara N" sort="Shenkier, Tamara N" uniqKey="Shenkier T" first="Tamara N." last="Shenkier">Tamara N. Shenkier</name>
<name sortKey="Shenkier, Tamara N" sort="Shenkier, Tamara N" uniqKey="Shenkier T" first="Tamara N." last="Shenkier">Tamara N. Shenkier</name>
<name sortKey="Shenkier, Tamara N" sort="Shenkier, Tamara N" uniqKey="Shenkier T" first="Tamara N." last="Shenkier">Tamara N. Shenkier</name>
</country>
<country name="Pays-Bas"><noRegion><name sortKey="Shenkier, Tamara N" sort="Shenkier, Tamara N" uniqKey="Shenkier T" first="Tamara N." last="Shenkier">Tamara N. Shenkier</name>
</noRegion>
</country>
<country name="Allemagne"><region name="Berlin"><name sortKey="Shenkier, Tamara N" sort="Shenkier, Tamara N" uniqKey="Shenkier T" first="Tamara N." last="Shenkier">Tamara N. Shenkier</name>
</region>
</country>
<country name="Italie"><region name="Lombardie"><name sortKey="Shenkier, Tamara N" sort="Shenkier, Tamara N" uniqKey="Shenkier T" first="Tamara N." last="Shenkier">Tamara N. Shenkier</name>
</region>
</country>
<country name="Australie"><noRegion><name sortKey="Shenkier, Tamara N" sort="Shenkier, Tamara N" uniqKey="Shenkier T" first="Tamara N." last="Shenkier">Tamara N. Shenkier</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00A489 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00A489 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:05-0201572 |texte= Primary CNS lymphoma of T-cell origin: A descriptive analysis from the International Primary CNS Lymphoma Collaborative Group }}
This area was generated with Dilib version V0.6.33. |